Seven Eight Capital’s Pfizer PFE Stock Holding History

Seven Eight Capital’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-40,387	Closed	-$1.77M	–	577
2022 Q3	$1.77M	Buy	40,387 +14,109	+54%	+$686K	0.35%	79
2022 Q2	$1.38M	Buy	+26,278	New	+$1.34M	0.56%	38
2021 Q3	–	Sell	-17,586	Closed	-$689K	–	692
2021 Q2	$689K	Buy	17,586 +11,586	+193%	+$451K	0.1%	353
2021 Q1	$221K	Hold	6,000	–	–	0.05%	364
2020 Q4	$221K	Buy	+6,000	New	+$220K	0.05%	369
2020 Q2	–	Sell	-55,440	Closed	-$1.72M	–	506
2020 Q1	$1.72M	Buy	55,440 +23,562	+74%	+$803K	0.44%	58
2019 Q4	$1.19M	Buy	+31,878	New	+$1.14M	0.06%	428
2019 Q2	–	Sell	-70,349	Closed	-$2.83M	–	700
2019 Q1	$2.83M	Sell	70,349 -373,116	-84%	-$14.9M	0.15%	193
2018 Q4	$18.4M	Buy	+443,465	New	+$18.4M	1.03%	6
2017 Q4	–	Sell	-34,197	Closed	-$1.16M	–	550
2017 Q3	$1.16M	Buy	34,197 +34,150	+72,660%	+$1.1M	0.14%	230
2017 Q2	$2K	Hold	47	–	–	﹤0.01%	537
2017 Q1	$2K	Buy	+47	New	+$1.48K	﹤0.01%	492
2016 Q2	–	Sell	-62,023	Closed	-$1.74M	–	638
2016 Q1	$1.74M	Buy	+62,023	New	+$1.77M	0.74%	20
2015 Q1	–	Sell	-47	Closed	-$1K	–	634
2014 Q4	$1K	Sell	47 -14,919	-100%	-$428K	﹤0.01%	459
2014 Q3	$420K	Buy	+14,966	New	+$420K	0.32%	93
2014 Q1	–	Sell	-29,300	Closed	-$851K	–	450
2013 Q4	$851K	Buy	+29,300	New	+$853K	0.95%	6

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Seven Eight Capital's PFE Position: Q4 2022 in Review

Seven Eight Capital sold out of Pfizer (PFE) in Q4 2022, closing a stake of 40,387 shares — an estimated $1.77M sold.

Seven Eight Capital first reported a position in PFE in Q4 2013 and held it in 16 quarters. The position peaked at $18.4M in Q4 2018. 3,268 funds tracked by Wall St. Rank hold PFE as of Q4 2022.

Seven Eight Capital reported no remaining Pfizer position as of Q4 2022 after selling out during the quarter.
Seven Eight Capital sold 40,387 Pfizer shares in Q4 2022, an estimated $1.77M.
Seven Eight Capital first reported a position in Pfizer in Q4 2013 and held it in 16 quarters.
Seven Eight Capital's Pfizer position peaked at $18.4M in Q4 2018.
3,268 funds tracked by Wall St. Rank held Pfizer as of Q4 2022.

Based on Seven Eight Capital's 13F filing for Q4 2022, filed 13 Feb 2023.